<SEC-DOCUMENT>0001570562-26-000083.txt : 20260804
<SEC-HEADER>0001570562-26-000083.hdr.sgml : 20260804
<ACCEPTANCE-DATETIME>20260804084607
ACCESSION NUMBER:		0001570562-26-000083
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260803
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260804
DATE AS OF CHANGE:		20260804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Evolus, Inc.
		CENTRAL INDEX KEY:			0001570562
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				461385614
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38381
		FILM NUMBER:		261235685

	BUSINESS ADDRESS:	
		STREET 1:		520 NEWPORT CENTER DRIVE
		STREET 2:		SUITE 1200
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
		BUSINESS PHONE:		(949) 284-4555

	MAIL ADDRESS:	
		STREET 1:		520 NEWPORT CENTER DRIVE
		STREET 2:		SUITE 1200
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>eols-20260803.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019f8538-0fc8-750c-bc0c-b86b34fc9f7e,g:674955e1-d4bd-463e-9351-537d93b1c506,d:eccf15dc27414c88ab796f9d8abe74f0-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>eols-20260803</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001570562</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="eols-20260803.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001570562</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-03</xbrli:startDate><xbrli:endDate>2026-08-03</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ieccf15dc27414c88ab796f9d8abe74f0_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%">&#160;UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">August 3, 2026</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">EVOLUS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;padding-left:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.200%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.567%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38381</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">46-1385614</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</span></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">520 Newport Center Drive, Suite 1200</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Newport Beach</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">92660</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">949</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">284-4555</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric>&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric>&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric>&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric>&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.025%"><tr><td style="width:1.0%"/><td style="width:34.111%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title of Class</span></td><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.00001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">EOLS</ix:nonNumeric></span></td><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(Nasdaq Global Market)</span></div><div style="text-align:center"><span><br/></span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div></div><div id="ieccf15dc27414c88ab796f9d8abe74f0_7"></div><hr style="page-break-after:always"/><div style="min-height:13.5pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.01&#160;&#160;&#160;&#160;Entry into a Material Definitive Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Symatese License Amendment - Addition of Australia, New Zealand and Canada</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 3, 2026, Evolus Pharma B.V. (&#8220;Evolus Europe&#8221;), a wholly owned subsidiary of Evolus, Inc. (the &#8220;Company&#8221;), and Symatese Aesthetics S.A.S. (&#8220;Symatese&#8221;) entered into an amendment (the &#8220;Amendment&#8221;) to the License, Supply and Distribution Agreement dated December 20, 2023 (the &#8220;Agreement&#8221;), which the Company previously disclosed in a Current Report on Form 8-K filed on December 20, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Amendment expands the territory covered by the Agreement to include (i) Canada and (ii) Australia and New Zealand combined, and grants Evolus Europe exclusive rights to commercialize and distribute the full line of Estyme</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> branded injectable hyaluronic acid gels in those territories. As consideration for the additional rights, Evolus Europe is required to pay &#8364;920,000 in upfront signing payments and up to an additional &#8364;1.38 million upon receipt of certain regulatory approvals. Symatese will be responsible, at its expense, for the development and regulatory activities required to obtain and maintain regulatory approvals in the additional territories.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The initial term for each new territory is 15 years from the first applicable regulatory approval and will automatically renew for successive five-year terms, subject to the terms of the Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing is a summary of the terms of the Amendment and is qualified in its entirety by reference to the Amendment, a copy of which will be filed as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ending September 30, 2026.</span></div><div><span><br/></span></div><div id="ieccf15dc27414c88ab796f9d8abe74f0_10"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01&#160;&#160;&#160;&#160;Regulation FD Disclosure.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2026, the Company issued a press release announcing the execution of the Amendment. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As provided in General Instruction B.2 of Form 8-K, the information in this Item 7.01 (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div></div><div id="ieccf15dc27414c88ab796f9d8abe74f0_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:144%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="padding-left:63pt;text-indent:-63pt"><span><br/></span></div><div style="padding-left:90pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:144%">(d)&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-bottom:7pt"><span><br/></span></div><div style="margin-top:5pt;padding-left:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:9.044%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2.62pt 1pt 1.5pt 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-right:2.25pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a8k8426ex991.htm">Press Release of Evolus, Inc., dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a8k8426ex991.htm">August 4, 2026</a></span></div></td></tr><tr><td colspan="3" style="padding:2.62pt 1pt 1.5pt 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ieccf15dc27414c88ab796f9d8abe74f0_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:144%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:144%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:2pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Evolus, Inc.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dated: August&#160;4, 2026</span></div></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David Moatazedi</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">David Moatazedi</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2.62pt 1pt 1.5pt 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a8k8426ex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="id416426bfbcc49eab040809ccf0306cb_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:center"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:64px;margin-bottom:5pt;vertical-align:text-bottom;width:306px"></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#8239;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:15pt;font-weight:700;line-height:120%">Evolus&#160;Expands Strategic Partnership with Symatese to Commercialize  Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9.75pt;font-weight:700;line-height:120%;position:relative;top:-5.25pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:15pt;font-weight:700;line-height:120%"> in Canada, Australia, and New Zealand</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Establishes a complementary injectable hyaluronic acid (HA) gel portfolio alongside Jeuveau</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> and Nuceiva</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> across all Evolus commercial markets</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Further leverages Evolus&#8217; international commercial infrastructure to support long-term profitable growth</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">NEWPORT BEACH, Calif.,&#160;August 4, 2026&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8211;&#160;</font><font style="color:#0563c1;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Evolus, Inc.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;(NASDAQ&#58; EOLS),&#160;a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced&#160;it has expanded its partnership with Symatese through an amendment to the companies&#8217; existing licensing and distribution agreement, providing Evolus with the exclusive rights to commercialize the Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> (pronounced &#8220;esteem&#8221;) collection of injectable hyaluronic acid (HA) gels in Canada, Australia, and New Zealand.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">With this agreement and expected commercialization in 2028, Evolus will hold exclusive rights to commercialize its injectable HA gel portfolio in every market where it currently markets Jeuveau</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> and Nuceiva</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, establishing a consistent multi-product commercial platform across its global business. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The agreement further expands Evolus&#8217; long-standing partnership with Symatese and strengthens the company&#8217;s international injectable HA gel portfolio by extending Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, currently marketed in the United States under the brand name Evolysse</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, into three additional attractive aesthetic markets. Upon regulatory approval, Evolus expects to commercialize the full Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> collection across Canada, Australia, and New Zealand, complementing its existing Nuceiva</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> neurotoxin franchise. Together, the neurotoxin and dermal filler markets across Canada, Australia, and New Zealand represent a total addressable market of approximately $500 million annually, with approximately 60% attributable to neurotoxins and 40% to dermal fillers.     </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;The addition of Canada, Australia and New Zealand is the final step that allows Evolus to offer the portfolio of Nuceiva</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> and Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> in every international market where we compete,&#8221; said David Moatazedi, President and Chief Executive Officer of Evolus. &#8220;From the beginning, our vision has been to provide customers with a complementary portfolio of best-in-class injectable products that can address the range of aesthetic patient needs. This alignment of our portfolio ensures we can deliver a consistent Evolus experience, strengthens our competitive position, and allows us to maximize the long-term value of the commercial platform we have built.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Neurotoxins and HA dermal fillers are the two largest categories in injectable aesthetics and are increasingly used together as part of comprehensive facial treatment plans. The Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> collection features injectable HA gels utilizing Symatese&#8217;s innovative Cold-X</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> technology that is designed to preserve the natural structure of the HA molecule, providing long-lasting, natural-looking results. By expanding Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> into Canada, Australia, and New Zealand, Evolus expects to enhance its value </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">proposition by providing customers with complementary injectable products through an established commercial organization, creating greater scale across its international business.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Under the terms of the agreement, Symatese will remain responsible for product development, manufacturing, clinical support, and regulatory activities required to obtain and maintain marketing approvals within the licensed territories. Evolus will make an upfront payment to Symatese along with additional payments tied to the achievement of specified regulatory approval milestones. Evolus will also purchase product from Symatese at an agreed transfer price and pay a mid-single digit royalty based on net sales. The agreement is expected to be accretive to Evolus&#8217; international gross margins while leveraging the company&#8217;s existing commercial organization, digital platform, and distribution infrastructure across these markets. Commercialization of Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> in Canada, Australia, and New Zealand is expected in 2028, subject to applicable regulatory approvals and review processes.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">About Evolus, Inc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Evolus (NASDAQ&#58; EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics by building a differentiated portfolio of injectable brands that address the evolving needs of practitioners and patients. Our portfolio includes Jeuveau</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;(prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, Evolysse</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, a collection of unique injectable hyaluronic acid (HA) gels, and Profhilo</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, the market-leading injectable for skin quality in Europe, which Evolus has exclusively licensed for development and commercialization in the United States. Visit us at&#160;</font><font style="color:#467886;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">www.evolus.com</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, and follow us on </font><font style="color:#467886;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">LinkedIn</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">,&#160;</font><font style="color:#467886;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">X</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">,&#160;</font><font style="color:#467886;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Instagram</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;or&#160;</font><font style="color:#467886;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Facebook</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.&#160;&#160;  &#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8239;&#8239;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">This press release&#160;contains&#160;forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties, including statements about future or&#160;anticipated&#160;events, our business, financial condition, results of operations and prospects, our&#160;industry&#160;and the regulatory environment in which we&#160;operate. Any statements&#160;contained&#160;herein&#160;that are not statements of historical or current facts are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; or the negative of those terms, or other comparable terms intended to identify statements about the future. The company&#8217;s forward-looking statements include, but are not limited to, statements&#160;related to the anticipated benefits of the licensing and distribution agreement with Symatese&#59; the planned development, regulatory approval and commercialization of the Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">collection in Canada, Australia, and New Zealand&#59; the size of the injectable HA market in Canada, Australia, and New Zealand, and the expected impact on the company's financial results and profitability.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The forward-looking statements included&#160;herein&#160;are based on our current expectations, assumptions,&#160;estimates&#160;and projections, which we believe to be reasonable, and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements. These risks and uncertainties, all of which are difficult or impossible to predict accurately and many of which are beyond our control, include, but are not limited to uncertainties associated with our ability to comply with the terms and conditions in the&#160;Medytox&#160;Settlement Agreements, our ability to fund our future operations or obtain financing to fund our operations, our reliance on consumer discretionary spending, unfavorable global economic conditions including trade </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">disputes, tariffs and regulatory actions on imports, &#160;uncertainties related to customer and consumer adoption of&#160;Jeuveau</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and&#160;Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#47;Evolysse</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, the efficiency and operability of our digital platform, competition and market dynamics, our ability to successfully launch and commercialize our products in new markets, including the Evolysse</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Hyaluronic Acid (HA) gels in the U.S. and&#160;Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;HA gels outside the U.S., our ability to maintain regulatory approvals of&#160;Jeuveau</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and&#160;Evolysse</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;or obtain regulatory approvals for new product candidates or indications, our reliance on&#160;Symatese&#160;to achieve and&#47;or maintain regulatory approval for the&#160;Evolysse</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;HA gel products in the U.S., and other risks described in our filings with the Securities and Exchange Commission, including in the section entitled &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 filed with the Securities and Exchange Commission on or about May 4, 2026. These filings can be accessed online at&#160;</font><font style="color:#467886;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by law, we undertake no obligation to update or revise any forward-looking statements to reflect&#160;new information, changed circumstances or unanticipated events. If we do update or revise one or more of these statements, investors and others should not conclude that we will make&#160;additional&#160;updates or corrections.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Jeuveau</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">,&#160;Nuceiva</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, and&#160;Evolysse</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;are registered trademarks of&#8239;Evolus, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Estyme</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8239;and Cold-X</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;are&#160;registered&#160;trademarks&#160;of&#8239;Symatese&#8239;Aesthetics S.A.S.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Profhilo</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> is a registered trademark of IBSA Institut Biochimique SA.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">###</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Investors&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Phone&#58; (248) 202-9267</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#8239;ir&#64;evolus.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Media</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#8239;media&#64;evolus.com&#8239;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>eols-20260803.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019f8538-0fc8-750c-bc0c-b86b34fc9f7e,g:674955e1-d4bd-463e-9351-537d93b1c506-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:eols="http://www.evolus.com/20260803" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.evolus.com/20260803">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eols-20260803_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eols-20260803_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.evolus.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>eols-20260803_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019f8538-0fc8-750c-bc0c-b86b34fc9f7e,g:674955e1-d4bd-463e-9351-537d93b1c506-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_019f8538-0fc9-7de8-be7f-cdca680fa5aa_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_019f8538-0fc9-75e6-80fe-d92572330e53_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019f8538-0fc9-7e7f-889b-5f3864c6af7f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019f8538-0fc9-7a09-9d8b-c67c051fc944_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_019f8538-0fc9-79d0-91fa-302eb85c4b14_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_019f8538-0fc9-75cd-a781-de27a4b7a508_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_019f8538-0fc9-7f2d-a22a-91922caed456_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019f8538-0fc9-7658-b665-85d8ca1627d8_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019f8538-0fc9-7928-a867-49812f29314d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_019f8538-0fc9-7d49-9101-afed6e7f1bbe_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019f8538-0fc9-785a-b3f3-8981d1e19032_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019f8538-0fc9-799e-b18d-99bee7c24682_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019f8538-0fc9-7abb-903b-621425c0ba49_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019f8538-0fc9-7371-90a7-aeb3213b01c8_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019f8538-0fc9-78e1-bb73-a89ec8c2cb20_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019f8538-0fc9-7466-8397-d085fc5fe785_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019f8538-0fc9-7c83-9a21-aad2856e735b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019f8538-0fc9-7257-819a-4f6e1dd2ec4b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019f8538-0fc9-798a-8360-a9ec346c5d55_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019f8538-0fc9-7ea2-9c92-6e7e13dabbec_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019f8538-0fc9-78ff-924f-3011d95b65bd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019f8538-0fc9-7321-ac8f-fe143b530766_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019f8538-0fc9-735e-ae82-7bca9ccd033a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019f8538-0fc9-789f-8240-b3401c93381b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>eols-20260803_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019f8538-0fc8-750c-bc0c-b86b34fc9f7e,g:674955e1-d4bd-463e-9351-537d93b1c506-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.evolus.com/role/CoverPage" xlink:type="simple" xlink:href="eols-20260803.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.evolus.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019f8538-0fc9-74af-8c0b-c15f7ed41484" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_DocumentType_019f8538-0fc9-74af-8c0b-c15f7ed41484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019f8538-0fc9-77e6-8002-fc39fa9b05c7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_DocumentPeriodEndDate_019f8538-0fc9-77e6-8002-fc39fa9b05c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019f8538-0fc9-7cb8-93f2-aaa2314ba521" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_EntityRegistrantName_019f8538-0fc9-7cb8-93f2-aaa2314ba521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019f8538-0fc9-7de8-a20b-b92dd979f321" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019f8538-0fc9-7de8-a20b-b92dd979f321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019f8538-0fc9-7f60-8188-745dbc62aa50" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_EntityFileNumber_019f8538-0fc9-7f60-8188-745dbc62aa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019f8538-0fc9-76d4-9f67-cc928a29e741" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_EntityTaxIdentificationNumber_019f8538-0fc9-76d4-9f67-cc928a29e741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019f8538-0fc9-7cc3-bd02-f96996397932" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_EntityAddressAddressLine1_019f8538-0fc9-7cc3-bd02-f96996397932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019f8538-0fc9-7858-995d-d7255c82c332" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_EntityAddressCityOrTown_019f8538-0fc9-7858-995d-d7255c82c332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019f8538-0fc9-70e2-a974-13fe47140ecd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_EntityAddressStateOrProvince_019f8538-0fc9-70e2-a974-13fe47140ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019f8538-0fc9-7e65-8612-774ec432fa8e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_EntityAddressPostalZipCode_019f8538-0fc9-7e65-8612-774ec432fa8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019f8538-0fc9-76fd-9bf2-200f1bbfe6a1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_CityAreaCode_019f8538-0fc9-76fd-9bf2-200f1bbfe6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019f8538-0fc9-7929-900d-6f704cdc55e6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_LocalPhoneNumber_019f8538-0fc9-7929-900d-6f704cdc55e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_019f8538-0fc9-7ffd-9a4e-f701807e68cb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_WrittenCommunications_019f8538-0fc9-7ffd-9a4e-f701807e68cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_019f8538-0fc9-7398-85d6-7f7e054c0758" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_SolicitingMaterial_019f8538-0fc9-7398-85d6-7f7e054c0758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_019f8538-0fc9-775a-982d-0a78f007f369" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_PreCommencementTenderOffer_019f8538-0fc9-775a-982d-0a78f007f369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_019f8538-0fc9-7ed7-95ed-775f62c3acbc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_019f8538-0fc9-7ed7-95ed-775f62c3acbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019f8538-0fc9-7544-a6de-957f9a3f6f97" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_Security12bTitle_019f8538-0fc9-7544-a6de-957f9a3f6f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019f8538-0fc9-7347-b6fb-53437968237e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_TradingSymbol_019f8538-0fc9-7347-b6fb-53437968237e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019f8538-0fc9-7a6d-8a96-588ab58c4095" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_SecurityExchangeName_019f8538-0fc9-7a6d-8a96-588ab58c4095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019f8538-0fc9-759a-9c1d-d56ebe931083" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_EntityEmergingGrowthCompany_019f8538-0fc9-759a-9c1d-d56ebe931083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_019f8538-0fc9-7d33-b513-642b7f27f194" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_EntityExTransitionPeriod_019f8538-0fc9-7d33-b513-642b7f27f194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019f8538-0fc9-71cc-b72c-305b9a1c6139" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_EntityCentralIndexKey_019f8538-0fc9-71cc-b72c-305b9a1c6139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019f8538-0fc9-744f-923f-786167c79bc8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_AmendmentFlag_019f8538-0fc9-744f-923f-786167c79bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019f8538-0fc9-70a2-9ece-af3f68b6b41d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019f8538-0fc9-705f-a7f9-06fcfe299241" xlink:to="loc_dei_CurrentFiscalYearEndDate_019f8538-0fc9-70a2-9ece-af3f68b6b41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
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M&;=.L321MGUXX4&%\0K8RH%$6:L99)2X9&>$)&59N.^^5K/-9UAC!";\LJ,
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M!R P_O'4_JYI70,=T\QCC]DM'1T=SAETW>U?ZOJ6$#7+9.JP*"LF:RK3-MF
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MYRID6J&A*%4#'<QKE JJO![9QY8PS/S8REXT*Q2&#2YTUG)6!)2;O)C%IDD
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M6PXH\N##]][QLOX3%K]HX_+C%VQ8LH3O;UG_W!L:DH:.:N7EPF*M#)V K*8
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A]B#\    !DE$050# +; /3:ZAC%/     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Aug. 03, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  03,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EVOLUS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-1385614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">520 Newport Center Drive, Suite 1200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Newport Beach<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">284-4555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EOLS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001570562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="eols-20260803.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.evolus.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="eols-20260803.htm">eols-20260803.htm</File>
    <File>eols-20260803.xsd</File>
    <File>eols-20260803_lab.xml</File>
    <File>eols-20260803_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "eols-20260803.htm": {
   "nsprefix": "eols",
   "nsuri": "http://www.evolus.com/20260803",
   "dts": {
    "inline": {
     "local": [
      "eols-20260803.htm"
     ]
    },
    "schema": {
     "local": [
      "eols-20260803.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "eols-20260803_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "eols-20260803_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.evolus.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eols-20260803.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eols-20260803.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.evolus.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001570562-26-000083-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001570562-26-000083-xbrl.zip
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M*<0\*3:=5JQ.@UY;-Y$N[?X8P6\V[ R8;/  R-/GI\W_'A()KVON1(I2<-Z
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MUO:.#T*QEI@[(IHL\/>Z?Q+H\VR^WWM?2Q?(=^'?R?J._WVN_P-02P,$%
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M/FT&FN^&4TGZK9M,9;_O0Z%94=Y%OI^^V3V3;3ZY^?3-_P%02P,$%     @
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MI.'CA=]P<O"PH_JH_HGFY. _4$L! A0#%     @ PF4$7<FL")+F$0  IFL
M !               ( !     &$X:S@T,C9E>#DY,2YH=&U02P$"% ,4
M" #"901=_#%R:'42  #*;@  $0              @ $4$@  96]L<RTR,#(V
M,#@P,RYH=&U02P$"% ,4    " #"901=UT'XQV4"    !P  $0
M    @ &X)   96]L<RTR,#(V,#@P,RYX<V102P$"% ,4    " #"901=AG".
ME-P)  ")6P  %0              @ %,)P  96]L<RTR,#(V,#@P,U]L86(N
M>&UL4$L! A0#%     @ PF4$7=BC9HX]!@  %#4  !4              ( !
M6S$  &5O;',M,C R-C X,#-?<')E+GAM;%!+!08     !0 % $(!  #+-P
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>eols-20260803_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="eols-20260803.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001570562</identifier>
        </entity>
        <period>
            <startDate>2026-08-03</startDate>
            <endDate>2026-08-03</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001570562</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2026-08-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">EVOLUS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38381</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">46-1385614</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">520 Newport Center Drive, Suite 1200</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Newport Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">92660</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">284-4555</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">EOLS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
